Korro Bio, Inc. (KRRO) NASDAQ

11.76

-0.53(-4.31%)

Updated at February 12 04:00PM

Currency In USD

Valuation

Market Cap339.61M
Enterprise Value328.73M
P/E Ratio-1.25
PEG Ratio-0.36
Price/Sales Ratio15.02
Price/Book Ratio1.12
Enterprise/Revenue17.67
Enterprise/EBITDA-1.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-12
Operating Margin-12.82

Management Effectiveness

Return On Assets-0.55
Return On Equity-0.69

Income Statement

Revenue2.27M
Revenue/Share0.78
Gross Profit2.27M
EBITDA-88.35M
Net Income-83.58M
Diluted EPS-9.37

Balance Sheet

Total Cash93.48M
Total Cash/Share9.95
Total Debt44.67M
Total Debt/Equity0.45
Current Ratio6.71
Book Value Per Share10.54

Price History

52-Week Change-59.56
52-Week High55.89
52-Week Low5.2
Moving Average 50 Days9.21
Moving Average 200 Days19.18

Statistics

Average Volume366,043
Shares Outstanding9.42M
% Held by Institutions103.51

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateNovember 06, 2023